Reduction in treatment times through formalized data feedback: results from a prospective multicenter study of

Karl Heinrich Scholz1, Sebastian K G Maier, Jens Jung

  • 1Department of Cardiology, St. Bernward-Hospital, Hildesheim, Germany. prof.dr.k.scholz@bernward-khs.de

Insights

Systematic data analysis and feedback significantly reduced treatment times for ST-elevation myocardial infarction (STEMI) patients. This improvement in care also led to a better prognosis, especially for high-risk individuals receiving timely interventions.

Area of Science:

  • Cardiology
  • Health Services Research
  • Clinical Quality Improvement

Background:

  • ST-segment elevation myocardial infarction (STEMI) treatment times are critical for patient outcomes.
  • Formalized data feedback mechanisms may optimize emergency cardiac care pathways.

Purpose of the Study:

  • To assess the impact of systematic data analysis and standardized feedback on STEMI treatment durations.
  • To evaluate the effect of these interventions on patient mortality in a multicenter setting.

Main Methods:

  • A prospective multicenter trial involving 1,183 STEMI patients across primary percutaneous coronary intervention (PCI) and non-PCI hospitals.
  • Collection and quarterly review of quality indicators, including contact-to-balloon and door-to-balloon times.
  • Analysis of pre-hospital and in-hospital processes, such as patient pre-announcement and direct handoffs.

Main Results:

  • Median door-to-balloon time decreased from 71 to 58 minutes; contact-to-balloon time reduced from 129 to 103 minutes.
  • Increased direct handoffs to catheterization labs (22% to 38%) and primary transport to PCI facilities.
  • Significant reduction in one-year mortality for all patients and particularly for high-risk patients (TIMI risk score ≥ 3).

Conclusions:

  • Standardized data feedback effectively shortens treatment times for STEMI.
  • This quality improvement strategy is associated with an improved patient prognosis, most notably in high-risk STEMI populations.
  • The FITT-STEMI trial demonstrates the value of data-driven feedback in acute cardiac care.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...